COVID-19’s impact on healthcare executives’ compensation: Insights from Pearl Meyer’s managing director

As part of our Leadership Perspectives video series, Heidrick & Struggles’ Scott Sette spoke to Steve Sullivan, managing director of Pearl Meyer, a leading executive compensation consulting firm, to learn more about how COVID-19 has impacted the compensation of healthcare executives. In this video, Sullivan begins the conversation by providing an overview of the leading trends in not-for-profit healthcare prior to the pandemic, and then continues on to describe how the pandemic impacted the compensation of healthcare executives. He then discusses how the role of healthcare boards has changed, particularly the evolution of the compensation committees, and how incentive compensation programs are continuing to address issues such as DE&I and ESG, as well as remote working and other changes we’ve seen as a result of COVID-19. Finally, he talks about some the current leadership challenges facing healthcare organizations.

About the interviewer

Scott Sette (ssette@heidrick.com) is a partner in Heidrick & Struggles’ Houston office and a member of the Healthcare & Life Sciences Practice.